Test ID BLOD1291 Interleukin 2 Receptor Alpha Soluble, Plasma
Ordering Guidance
If this test is ordered with TH1CP / T-Helper Cell Type 1 Cytokine Panel, Plasma or CYTOP / Cytokine Panel, Plasma, this test will be canceled as duplicate and TH1CP or CYTOP performed as ordered.
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Lavender top (EDTA)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL Plasma
Collection Instructions:
1. Immediately after specimen collection, place the tube on wet ice.
2. Within 2 hours of collection, centrifuge at 4° C, 1500 x g for 10 minutes, and aliquot plasma into a plastic vial.
3. Freeze immediately.
Additional Information:
1. Plasma for this test cannot be shared with other tests. Submit specimen for this test in its own vial.
2. This test cannot be added onto a previously collected specimen.
3. If a refrigerated centrifuge is not available, it is acceptable to use a room temperature centrifuge, provided the sample is kept on ice before centrifugation and is frozen immediately afterward.
Secondary ID
624125Useful For
Measuring the concentration of soluble interleukin 2 receptor alpha (sIL-2Ra) in plasma
Aids in the diagnosis, evaluation and monitoring of patients with hemophagocytic lymphohistiocytosis, macrophage activation syndrome, sarcoidosis, and lymphoid malignancies
Method Name
Immunoassay
Reporting Name
IL-2 Receptor Alpha Soluble, PSpecimen Type
Plasma EDTASpecimen Minimum Volume
Plasma: 0.3 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Plasma EDTA | Frozen | 14 days |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | Reject |
| Gross icterus | Reject |
| Heat-treated specimen | Reject |
Reference Values
<18 years: Not established
≥18 years: ≤1929 pg/mL
Day(s) Performed
Thursday
Report Available
2 to 8 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83520